1. Home
  2. NICE Guidance
  3. Conditions and diseases
  4. Cancer
  5. Metastases

Apalutamide with androgen deprivation therapy for treating hormone-sensitive metastatic prostate cancer

Technology appraisal guidance [TA741] Published: 28 October 2021

  • Guidance
  • Tools and resources
  • Information for the public
  • Evidence
  • History